Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.

× No keyword cloud information.

54 in total

Review 1. Pharmacoeconomics of hypertension management: the place of combination therapy.

Authors: E Ambrosioni
Journal: Pharmacoeconomics Date: 2001 Impact factor: 4.981

2. Issues of clinical trial design and data interpretations in hypertension.

Authors: L H Kuller
Journal: Curr Hypertens Rep Date: 1999-08 Impact factor: 5.369

3. Preventing stroke with ramipril. Results should have been presented in ways that help practising clinicians.

Authors: P Badrinath
Journal: BMJ Date: 2002-08-24

Review 4. Noncompliance with antihypertensive therapy. Economic consequences.

Authors: T L Skaer; D A Sclar; L M Robison
Journal: Pharmacoeconomics Date: 1996-01 Impact factor: 4.981

5. Intensified glucose lowering in type 2 diabetes: time for a reappraisal.

Authors: J S Yudkin; B Richter; E A M Gale
Journal: Diabetologia Date: 2010-08-05 Impact factor: 10.122

6. Changes in blood pressure during induction of anesthesia and oral and maxillofacial surgery by type and timing of discontinuation of antihypertensive drugs.

Authors: Yoshihiro Momota; Kazuhiro Kaneda; Kumiko Arishiro; Naotaka Kishimoto; Seiji Kanou; Junichiro Kotani
Journal: Anesth Prog Date: 2010

Review 7. The latest generation of beta-blockers: new pharmacologic properties.

Authors: Michala E Pedersen; John R Cockcroft
Journal: Curr Hypertens Rep Date: 2006-08 Impact factor: 5.369

Review 8. Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials.

Authors: Guido Grassi; Francesca Arenare; Fosca Quarti Trevano; Raffaella Dell'Oro; And Giuseppe Mancia
Journal: Curr Hypertens Rep Date: 2007-08 Impact factor: 5.369

9. Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes.

Authors: Polly J Bingley; Diane K Wherrett; Ann Shultz; Lisa E Rafkin; Mark A Atkinson; Carla J Greenbaum
Journal: Diabetes Care Date: 2018-04 Impact factor: 19.112

Review 10. Apparent and true resistant hypertension: definition, prevalence and outcomes.

Authors: E Judd; D A Calhoun
Journal: J Hum Hypertens Date: 2014-01-16 Impact factor: 3.012